ADO anticorps

N° du produit ABIN7241939

Détail du produit anti-ADO anticorps

Antigène: ADO (2-Aminoethanethiol (Cysteamine) Dioxygenase (ADO))

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ADO est non-conjugé

Application: ELISA, Western Blotting (WB), Immunohistochemistry (IHC)

Attributs du produit: Polyclonal Antibody

Purification: Affinity purification

Immunogène: Synthetic peptide of human ADO

Isotype: IgG

Information d'application

Indications d'application: WB 1:1000-1:5000, IHC 1:25-1:100

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.3 mg/mL

Buffer: PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur ADO

Antigène: ADO (2-Aminoethanethiol (Cysteamine) Dioxygenase (ADO))

Autre désignation: ADO (ADO Produits)

Synonymes: anticorps C10orf22, anticorps Gm237, anticorps RGD1308233, anticorps wu:fc32g01, anticorps wu:fc52c12, anticorps zgc:101580, anticorps 2-aminoethanethiol dioxygenase, anticorps 2-aminoethanethiol (cysteamine) dioxygenase, anticorps 2-aminoethanethiol (cysteamine) dioxygenase a, anticorps ADO, anticorps Ado, anticorps LOC100351598, anticorps adoa

Sujet: Human thiol dioxygenases include cysteine dioxygenase (CDO, MIM 603943) and cysteamine (2-aminoethanethiol) dioxygenase (ADO, EC 1.13.11.19). CDO adds 2 oxygen atoms to free cysteine, whereas ADO adds 2 oxygen atoms to free cysteamine to form hypotaurine. Mouse Ado has strong and specific dioxygenase activity in vitro towards cysteamine but not cysteine. Recombinant Ado was shown to bind iron. Overexpression of Ado in HepG2/C3A cells increased the production of hypotaurine from cysteamine. Similar results were found with human ADO. When endogenous expression of ADO was reduced by RNA-mediated interference, hypotaurine production decreased. The demonstration of high levels of ADO in brain challenges the previous assumption that most of the taurine in the brain is a consequence of CDO activity.

Poids moléculaire: 30 kDa

NCBI Accession: NP_116193

UniProt: Q96SZ5